BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon

Reuters03-04

March 3 (Reuters) - ABVC Biopharma Inc ABVC.O:

ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPON
ABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILING

Further company coverage: ABVC.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616372647?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 05:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616372647","market":"us","top_or_hot":-1,"title":"BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>ABVC Biopharma Inc <span>ABVC.O</span>:</p><ul><li><p>ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPON</p></li><li><p>ABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILING</p></li></ul><p>Further company coverage: <span>ABVC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-04 05:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon</title></head><body><p><span>March 3 (Reuters)</span><span> - </span>ABVC Biopharma Inc <span>ABVC.O</span>:</p><ul><li><p>ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPON</p></li><li><p>ABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILING</p></li></ul><p>Further company coverage: <span>ABVC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABVC","symbol_name":"ABVC BioPharma, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0RF:1","article_id":"2616372647","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2616372647","pubTimestamp":1772574761,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied UponMarch 3  - ABVC Biopharma Inc ABVC.O:ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPONABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILINGFurther company coverage: ABVC.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ABVC":"ABVC BioPharma, Inc.","BK4139":"生物科技"},"translate_title":"简介-ABVC Biopharma-截至2025年9月的季度财务报表不应依赖","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABVC":0.9},"content_text":"BRIEF-ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied UponMarch 3 (Reuters) - ABVC Biopharma Inc ABVC.O:ABVC BIOPHARMA - QTRLY PERIOD ENDED SEPTEMBER, 2025 FINANCIAL STATEMENTS SHOULD NOT BE RELIED UPONABVC BIOPHARMA INC - REPORTS MATERIAL WEAKNESS IN INTERNAL CONTROLS OVER FINANCIAL REPORTING FOR FY2025 - SEC FILINGFurther company coverage: ABVC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616372647","isCrawlerRequest":true}